Journal profile · PATHOLOGY
Journal of Pathology and Translational Medicine
ISSN 2383-7837 · eISSN 2383-7845 · Korean Society of Pathologists & the Korean Society for Cytopathology · Korea, Republic of
Journal of Pathology and Translational Medicine: CAS Zone 4 · Medicine (2025 upgraded edition); fully open access; APC about USD 175; median 69 days to acceptance (86 articles, last 24 months); 50 articles in 2025; indexed in ESCI and Scopus; the journal's website says it has moved to a new publisher.
The journal's website says it has moved to a new publisher: JPTM provides the electronic backup and preservation of access to the journal content in the event the journal is no longer published by archiving in PubMed Central. Source ↗Publisher website ·
Scope
Aims, scope and focus
Journal of Pathology and Translational Medicine is published by Korean Society of Pathologists & the Korean Society for Cytopathology and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Sarcoma Diagnosis and Treatment, Thyroid Cancer Diagnosis and Treatment and Salivary Gland Tumors Diagnosis and Treatment, together about 21.4% of its articles. Its main subfields are Pathology and Forensic Medicine. (generated from OpenAlex topic counts and CAS ranking data)
The Journal of Pathology and Translational Medicine is an open venue for the rapid publication of major achievements in various fields of pathology, cytopathology, and biomedical and translational research. The Journal aims to share new insights into the molecular and cellular mechanisms of human diseases and to report major advances in both experimental and clinical medicine, with a particular emphasis on translational research. The investigations of human cells and tissues using high-dimensional biology techniques such as genomics and proteomics will be given a high priority. Articles on stem cell biology are also welcome. The manuscript types include original articles, review articles, case studies, and letters to the editor.
From the journal's Aims & Scope
Research area (LetPub): PATHOLOGY
Editorial board by country: 2 in mainland China (about 4%); most named South Korea 28, Japan 5, United States 4, Mainland China 2, Hong Kong, China 2 (52 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Sarcoma Diagnosis and TreatmentMedicine8.2%
- Thyroid Cancer Diagnosis and TreatmentMedicine7.3%
- Salivary Gland Tumors Diagnosis and TreatmentMedicine5.9%
- Lymphoma Diagnosis and TreatmentMedicine5.5%
- Cervical Cancer and HPV ResearchMedicine4.6%
- Genetic factors in colorectal cancerMedicine4.4%
- Cancer and Skin LesionsMedicine4.2%
- Lung Cancer Treatments and MutationsMedicine4.1%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Pathology | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Pathology | Zone 3 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Not covered
Not covered by this edition.
Database indexing
ESCIScopusDOAJLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- CiteScore 2026-06
- 3.8LetPub ·
- CiteScore (publisher)
- 75Publisher website ·
- SJR 2026-06
- 0.95LetPub ·
- SNIP 2026-06
- 1.18LetPub ·
- h-index
- 51OpenAlex ·
- i10-index
- 500OpenAlex ·
- 2-year mean citedness
- 2.28OpenAlex ·
- Self-citation rate
- 3.3%LetPub ·
- Share of gold OA articles
- 100%LetPub ·
Volume
- Articles per year
- 44LetPub ·
Articles by year OpenAlex count · 1,508 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 51 | 51 | 19 |
| 2025 | 50 | 50 | 97 |
| 2024 | 46 | 46 | 219 |
| 2023 | 40 | 40 | 530 |
| 2022 | 44 | 44 | 402 |
| 2021 | 56 | 56 | 502 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with Crossref · to
69 daysMedian, submission to acceptance · P25–P75 40 days – 103 days
- Acceptance to online
- median 87 days (86 articles)
- Submission to online
- median 163 days
- Sample
- 86 articles with submission and acceptance dates (114 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- about 14 weeksLetPub ·
- Submission to publication (journal-reported)
- about 14 weeksDOAJ ·
- Peer review
- Single anonymous peer reviewDOAJ
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Fully open accessDOAJ
Every article is open access; authors usually pay an article processing charge (APC).
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| DOAJ | USD 175 | No | CC BY-NC | |
| OpenAlex | USD 175 | — | — | |
| LetPub | USD 175 | No | — | |
| Publisher website | Yes, amount not published | — | — |
Other charges and waivers (author guidelines)
- Other fees
- USD 50
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
What to prepare6 items from the author guidelines
- Abstract
- ≤ 250 words
- Keywords
- 3–5
- Reference style
- Vancouver
- Templates
- Word
- First submission
- Free format: the journal's layout is not required
- Cover letter
- Required
Article types accepted9
- case studiesThe manuscript types include original articles, review articles, case studies, and letters to the editor.Length not stated
- hypothesis1. Original articles The arrangement of an original article is as follows: Title Page, Abstract and Keywords, Introduction, Materials and Methods, Results, Disc…Length not stated
- letters to the editorThe manuscript types include original articles, review articles, case studies, and letters to the editor.Length not stated
- letters to the editors4. Letters to the Editors The Editors welcome brief letters (not more than two A4 pages in length) commenting on articles appearing in recent issues, on general…Length not stated
- original article1. Original articles The arrangement of an original article is as follows: Title Page, Abstract and Keywords, Introduction, Materials and Methods, Results, Disc…Length not stated
- original articles1. Original articles The arrangement of an original article is as follows: Title Page, Abstract and Keywords, Introduction, Materials and Methods, Results, Disc…Length not stated
- review1. Original articles The arrangement of an original article is as follows: Title Page, Abstract and Keywords, Introduction, Materials and Methods, Results, Disc…Length not stated
- review articlesThe manuscript types include original articles, review articles, case studies, and letters to the editor.Length not stated
- reviews and editorials2. Reviews and Editorials Reviews and Editorials are normally by invitation only.Length not stated
Policy excerpts from the journal's websiteAuthorship, Conflicts of interest, Publication ethics, License & copyright, Open access, Peer review, Plagiarism, Trial registration / reporting guidelines
- Authorship 7) Author Contributions
Online submission required; manuscripts must meet ICMJE recommendations Model summary
JPTM participates in the CRediT standard for author contributions (https://casrai.org/credit/). The contributions of all authors must be described using the CRediT Taxonomy of author roles. For each of the categories below, please enter the initials of the authors who contributed in that category. If listing more than one author in a category, separate each set of initials with a coma. If no one c…
Source ↗Publisher website ·- Conflicts of interest 3) Disclosure of Potential Conflicts of Interest
A statement disclosing all relationships or interests that could have direct or potential influence on the work should be included in a separate section before the reference list. The authors will be held responsible for any false statements or failure to follow the ethical guidelines. Each author should have participated in the research and/or article preparation. All authors are responsible for …
Source ↗Publisher website ·- Publication ethics 1) Ethical Approval
Human studies must follow Declaration of Helsinki and have IRB/ethics committee approval Model summary
All studies on human subjects should follow the World Medical Association Declaration of Helsinki (1964) and the authors should provide an affirmation that the studies have been approved by the appropriate institutional review board (IRB) and/or national research ethics committee with relevant reference numbers and dates. The following statement should be included in the text at the end of the Mat…
Source ↗Publisher website ·- License & copyright COPYRIGHT, LICENSING, AND ARCHIVING POLICY
All published papers become the permanent property of the Korean Society of Pathologists and the Korean Society for Cytopathology. Copyrights of all published materials are owned by the Korean Society of Pathologists and the Korean Society for Cytopathology. Permission must be obtained from the Korean Society of Pathologists and the Korean Society for Cytopathology for any commercial use of materi…
Source ↗Publisher website ·- Open access
Open access journal Model summary
The Journal of Pathology and Translational Medicine is an open venue for the rapid publication of major achievements in various fields of pathology, cytopathology, and biomedical and translational research.
Source ↗Publisher website ·- Peer review REVIEW PROCESS
Single-blind peer review Model summary
1. Peer-Review Process All papers, including those invited by the Editor, are subject to peer review. Manuscripts are reviewed by at least 2 external experts and editors. Received manuscripts will be peer-reviewed and a primary editorial decision will be sent to the authors within 2 weeks after submission. The Editor is responsible for the final decision whether the manuscript is accepted or rejec…
Source ↗Publisher website ·- Plagiarism 4) Redundant Publication and Plagiarism
Redundant publication is defined as "reporting (publishing or attempting to publish) substantially the same work more than once, without attribution of the original source(s)". Characteristics of reports that are substantially similar include the following: (a) "at least one of the authors must be common to all reports (if there are no common authors, it is more likely plagiarism than redundant pu…
Source ↗Publisher website ·- Trial registration / reporting guidelines 2. Reporting Guidelines for Specific Study Designs
For the specific study design, such as randomized control studies, studies of diagnostic accuracy, meta-analyses, observational studies, and non-randomized studies, it is recommended that the authors follow the reporting guidelines. A good source of reporting guidelines is the EQUATOR Network (http://www.equator-network.org/home/) and the United States National Institutes of Health/National Librar…
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Korean Society of Pathologists & the Korean Society for Cytopathology
- Country or region
- Korea, Republic of
- Language
- English, Korean
- ISSN
- 2383-7837
- Electronic ISSN
- 2383-7845
- Latest issue on the website
- Volume 60 (July 2026)
- Official links
- Journal homepage ↗LetPub
- Submission system ↗Publisher website
- Author guidelines ↗DOAJ
- Aims & Scope ↗DOAJ
- APC information ↗DOAJ
- Open access statement ↗DOAJ
- License & copyright ↗DOAJ
- Peer review process ↗DOAJ
- Editorial board ↗DOAJ
FAQ
Frequently asked questions about Journal of Pathology and Translational Medicine
What CAS zone is Journal of Pathology and Translational Medicine in?
In the 2025 upgraded edition of the CAS Journal Ranking, Journal of Pathology and Translational Medicine is in Zone 4 of Medicine, and in Zone 4 of the minor category Pathology. In the 2026 Xinrui edition it is in Zone 3 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
How long does peer review take at Journal of Pathology and Translational Medicine?
Based on the dates recorded on 86 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 69 days (interquartile range 40–103 days); authors report an average review time of about 14 weeks. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What are the manuscript requirements of Journal of Pathology and Translational Medicine?
According to the journal's author guidelines: Abstract: ≤ 250 words; Keywords: 3–5; Reference style: Vancouver; Templates: Word; First submission: Free format: the journal's layout is not required; Cover letter: Required. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.
Where are the editorial board members of Journal of Pathology and Translational Medicine based?
Of the 52 board members whose country the journal's board page names, 2 (about 4%) are in mainland China; the countries named most often are South Korea (28), Japan (5) and United States (4). Counted from the institutions listed on the board page; for reference only.
Which databases index Journal of Pathology and Translational Medicine?
According to LetPub and DOAJ records, Journal of Pathology and Translational Medicine is indexed in ESCI, Scopus and DOAJ.
Is Journal of Pathology and Translational Medicine open access, and what is the APC?
Journal of Pathology and Translational Medicine is a fully open-access journal. APC about USD 175.
Sources and updates
The facts on this page come from LetPub, OpenAlex, DOAJ, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .